aTyr Pharma (LIFE) Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan

Go back to aTyr Pharma (LIFE) Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan
Life Technologies Corporation (NASDAQ: LIFE) Delayed: 42.02 +2.17 (5.45%)
Previous Close $39.85    52 Week High $10.93 
Open $39.76    52 Week Low $2.48 
Day High $42.55    P/E 15.51 
Day Low $39.67    EPS $2.71 
Volume 1,466,054